Risk Factors for Glaucoma in Musicians

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2012 by Maastricht University Medical Center.
Recruitment status was  Recruiting
Stichting Glaucoomfonds
Information provided by (Responsible Party):
Henny Beckers, Maastricht University Medical Center
ClinicalTrials.gov Identifier:
First received: August 10, 2012
Last updated: August 16, 2012
Last verified: August 2012

The purpose of this study is to determine the impact of playing wind instruments for the development of ocular hypertension and glaucoma, together with investigating the prevalence of visual problems and eye diseases in (professional) musicians.


Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Risk Factors for Glaucoma in Musicians

Resource links provided by NLM:

Further study details as provided by Maastricht University Medical Center:

Primary Outcome Measures:
  • IOP levels, including IOP peaks occurring during or directly after playing, and prevalence of glaucomatous field loss in players of wind instruments. [ Time Frame: One hour. ] [ Designated as safety issue: No ]
  • IOP peaks and variations during continuous IOP monitoring [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
    Several high-risk participants will be asked their permission to perform continuous IOP monitoring during 24 hours with a sensing contact lens.

Secondary Outcome Measures:
  • Risk factors for glaucoma and the prevalence of visual problems and eye disease among (professional) musicians [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    Participants of orchestras will be asked to fill in a questionnaire to collect demographic data together with data on musical history,ophthalmologic history and family history on glaucoma and ocular hypertension. From these participants, a selection will be invited for further screening.

Estimated Enrollment: 40
Study Start Date: October 2011
(Wind) musicians
Members of (professional) orchestras, especially wind instrument players.


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

(Professional) musicians, who play in symphony or wind orchestras.


Inclusion Criteria:

  • All full time or part time professional players of participating symphony or wind orchestras, including guest players.
  • Retired players, if possible.

Exclusion Criteria:

  • Difficulty in reading or speaking Dutch.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01667861

Contact: Henny JM Beckers, MD, PhD +31 43 387 73 76 henny.beckers@mumc.nl

University Eye Clinic, Maastricht University Medical Center Recruiting
Maastricht, Netherlands, 6202 AZ
Contact: Henny JM Beckers, MD, PhD    +31 43 387 7376    henny.beckers@mumc.nl   
Sub-Investigator: Marina van Kooten-Noordzij, MD         
Sub-Investigator: Ronald de Crom, MD         
Sub-Investigator: Agnes Michiels, MD         
Sponsors and Collaborators
Henny Beckers
Stichting Glaucoomfonds
Principal Investigator: Henny JM Beckers, MD, PhD Maastricht University Medical Center, NL
  More Information

No publications provided

Responsible Party: Henny Beckers, MD, PhD, FEBophth, Maastricht University Medical Center
ClinicalTrials.gov Identifier: NCT01667861     History of Changes
Other Study ID Numbers: NL25853.068.09/MEC09-2-112
Study First Received: August 10, 2012
Last Updated: August 16, 2012
Health Authority: Netherlands: Medical Ethics Review Committee (METC)

Keywords provided by Maastricht University Medical Center:
Wind instruments

Additional relevant MeSH terms:
Eye Diseases
Ocular Hypertension

ClinicalTrials.gov processed this record on May 21, 2015